122 results
Page 3 of 7
8-K
EX-99.2
bd9ksg zpxt698
20 Jan 21
Invitae Announces Proposed Public Offering of Common Stock
4:10pm
8-K
EX-99.1
2hw6jslr14 r03a
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K
EX-99.2
ox3wmg
12 Jan 21
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
6:06am
8-K/A
EX-99.1
aww7ugo92ava40my46
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.2
41jdl
23 Nov 20
Consolidated Financial Statements
12:00am
8-K/A
EX-99.3
6kchjb1 ykoutnf2aaiu
23 Nov 20
Consolidated Financial Statements
12:00am
8-K
EX-99.1
2us9 yl9lxo
5 Nov 20
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
4:24pm
8-K
EX-10.3
irfyja1rf4p um
5 Oct 20
Invitae Completes Transaction with ArcherDX to Bring Comprehensive Cancer Genetics and Precision Oncology to Patients Worldwide
4:17pm
424B3
zc5fh xzmnup7tpnr711
28 Aug 20
Prospectus supplement
4:31pm
8-K
EX-99.1
nkepirvz3ew0
4 Aug 20
Invitae Reports $46.2 Million in Revenue Driven by More Than 120,000 Samples Accessioned in the Second Quarter of 2020
4:13pm
425
pdj0m guta8
24 Jun 20
Business combination disclosure
5:11pm
8-K
EX-2.1
dn94c 3t6tdpg4t3mysh
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.1
68qx70ck
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm
8-K
EX-10.3
qnwqrjb5
24 Jun 20
Entry into a Material Definitive Agreement
5:08pm